REGENACY PHARMACEUTICALS, INC.

Profile

Company Names

REGENACY PHARMACEUTICALS, INC.

Addresses

303 WYMAN STREET, SUITE 300, WALTHAM, MA 02451

303 WYMAN STREET, SUITE 300, WALTHAM, MA 02451

Phone Numbers

617-415-5030

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$28,666,415.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-01-27 
$7,808,997.00 
$9,999,999.00 
$2,191,002.00 
Equity 
1
2020-03-24 
$20,857,418.00 
$40,707,421.00 
$19,850,003.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
CHIN 
DIRECTOR
REGENACY PHARMACEUTICALS, INC.
MARC 
 
COHEN 
EXECUTIVE OFFICER, DIRECTOR
ONCOPEP, INC.   |  C4 THERAPEUTICS, INC.   |  WRINKL, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  REGENACY PHARMACEUTICALS, INC.   |  ANGIOCRINE BIOSCIENCE, INC.   |  HOCKEY PARENT HOLDINGS, L.P.
MICHAEL 
L. 
HUANG 
DIRECTOR
REGENACY PHARMACEUTICALS, INC.
SIMON 
 
JONES 
EXECUTIVE OFFICER, DIRECTOR
REGENACY PHARMACEUTICALS, INC.   |  ALL ENGLAND LAWN TENNIS GROUND PLC   |  VOLTZ LABS TECHNOLOGY LTD
JOHN 
 
ROCHA 
EXECUTIVE OFFICER
REGENACY PHARMACEUTICALS, INC.
DAGUANG 
 
WANG 
DIRECTOR
REGENACY PHARMACEUTICALS, INC.   |  ONCORESPONSE INC
SHIXIANG 
 
YAN 
DIRECTOR
REGENACY PHARMACEUTICALS, INC.   |  MYROBALAN THERAPEUTICS HOLDING, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-02-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-27 
2020-04-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LOCUST WALK PARTNERS, LLC
156174